Description
Recombinant monoclonal antibody to Neurexin-1-Beta. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma N170A/1.1. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
Neurexin-1-Beta
Target Alias Names
N170A/1.1R, N170A/1, NRXN1, Neurexin I-beta
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression